Consistent with previous reports from the JUPITER trial and as specified in the protocol, cardiovascular events included those occurring at any time between randomisation and March 30, 2008, the date of un- masking of the trial. Since physician-reported diabetes was regarded as an adverse event, reports of this disease were included if they occurred any time between randomisation and the last study visit for each individual participant, a process that continued until August, 2008. All components of the JUPITER primary endpoint were adjudicated by an endpoints committee unaware of randomisation status using prespecified endpoint criteria. Incident events of diabetes and total mortality was based on filed reports.